| abstract |
Embodiments herein provide formulations and methods for the treatment of inflammatory skin diseases using allantoin in an amount of about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, but are not limited to, cutaneous porphyria, scleroderma, epidermolysis bullosa, psoriasis, decubitus ulcer, decubitus, diabetic ulcer, venous stasis ulcer Sickle cell ulcer, burn-induced ulcer, eczema, urticaria, atopic dermatitis, herpes dermatitis, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinoma, psoriasis, rosacea Post-operative care of sweat, skin infection, incision, post-operative skin care after any of various plastic surgery, skin care after radiation treatment, dry, cracked or age-related skin and skin line care, and skin Including other conditions that have an inflammatory component to affect, these symptoms, or a combination thereof. The condition being treated can include pain, inflammation, redness, pruritus, scarring, skin thickening, chalazion, or combinations thereof. [Selection figure] None |